Objective While numerous studies have highlighted an increased prevalence of depression
in individuals with narcolepsy, their conclusions are often clouded by potential confounding …

Abstract Narcolepsy type 1 (NT1) is a lifelong sleep disorder, primarily characterized
clinically by excessive daytime sleepiness and cataplexy and pathologically by the loss of …

Objective Narcolepsy is a lifelong disease, manifesting with excessive daytime sleepiness
and cataplexy, arising between childhood and young adulthood. The diagnosis is typically …

Background Narcolepsy is a chronic and debilitating sleep disorder characterized by
cataplexy and excessive daytime sleeping. Gamma-hydroxybutyrate (GHB) has been widely …

Introduction The present post hoc analysis was designed to evaluate health-related quality
of life (HRQoL) using the 36-item Short Form Health Status Survey (SF-36) during an 8-week …

Objectives The objective of the study was to evaluate the morbidities and mortality in a
national group of middle-aged and elderly narcolepsy patients before and after the first …

Purpose We aimed to evaluate the excess direct and indirect costs associated with epilepsy.
Methods From the Danish National Patient Registry (1998–2013), we identified people …

Objective To follow and analyze the clinical course and quality of life of Pandemrix H1N1-
vaccine-related narcolepsy (pNT1). Methods Twenty-six drug-naïve confirmed pNT1 …

Abstract Objective To validate the Japanese versions of the Ullanlinna Narcolepsy Scale (J-
UNS) and Swiss Narcolepsy Scale (J-SNS) for screening narcolepsy in the Japanese …

Introduction Narcolepsy is a chronic sleep disorder characterized by a pentad of excessive
daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic/hypnopompic …